Literature DB >> 10744927

Tumour micrometastases: the influence of angiogenesis.

C O McDonnell1, A D Hill, D A McNamara, T N Walsh, D J Bouchier-Hayes.   

Abstract

INTRODUCTION: Many cancer patients have undetected micrometastatic disease at first presentation which ultimately progresses. Angiogenesis-the development of an independent blood supply-is a key event in the growth of metastases. Improved understanding of the influence of angiogenesis on micrometastatic growth may lead to new therapeutic intervention.
METHODS: This study examines current concepts of the significance of micrometastases and the role of angiogenesis in their development and destruction. A comprehensive review of the literature on micrometastasis and angiogenesis was performed using the Medline database between 1966 and 1999.
CONCLUSIONS: Advances in technology have improved our ability to diagnose metastatic disease, but micrometastases in loco-regional lymph nodes and at distant sites can only be detected by sophisticated histological techniques. While the significance of micrometastases remains controversial, there is increasing evidence that micrometastatic status provides useful prognostic information and should be part of standard staging techniques. Anti-angiogenic therapy has the potential to favourably influence management of certain cancers by manipulating a number of key events in the metastatic process. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 10744927     DOI: 10.1053/ejso.1999.0753

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

1.  Orthotopic transplantation model of human gastrointestinal cancer and detection of micrometastases.

Authors:  J H Cui; U Krueger; D Henne-Bruns; B Kremer; H Kalthoff
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  De novo design of VEGFR-2 tyrosine kinase inhibitors based on a linked-fragment approach.

Authors:  Yi-Zhou Liu; Xiao-Li Wang; Xin-Ying Wang; Ri-Lei Yu; Dong-Qing Liu; Cong-Min Kang
Journal:  J Mol Model       Date:  2016-08-25       Impact factor: 1.810

3.  Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease.

Authors:  Antoinette Wetterwald; Gabri van der Pluijm; Ivo Que; Bianca Sijmons; Jeroen Buijs; Marcel Karperien; Clemens W G M Löwik; Elsbeth Gautschi; George N Thalmann; Marco G Cecchini
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

4.  Relationship between vascular invasion and microvessel density and micrometastasis.

Authors:  Yan-Dong Wang; Pei Wu; Jia-Ding Mao; He Huang; Fan Zhang
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

Review 5.  The tumor microenvironment and metastatic disease.

Authors:  Sarah Jane Lunt; Naz Chaudary; Richard P Hill
Journal:  Clin Exp Metastasis       Date:  2008-06-10       Impact factor: 5.150

6.  Oesophageal cancer metastases: An observational study of a more aggressive approach.

Authors:  Lianne Pickett; Mary Dunne; Orla Monaghan; Liam Grogan; Oscar Breathnach; Thomas N Walsh
Journal:  World J Gastrointest Surg       Date:  2022-09-27

7.  The clinical impact of mean vessel size and solidity in breast carcinoma patients.

Authors:  Lars Tore Gyland Mikalsen; Hari Prasad Dhakal; Øyvind S Bruland; Bjørn Naume; Elin Borgen; Jahn M Nesland; Dag Rune Olsen
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

8.  Contrast enhanced computed tomography is indicative for angiogenesis pattern and display prognostic significance in breast cancer.

Authors:  Jianyi Li; Yang Zhang; Wenhai Zhang; Yang Gao; Shi Jia; Jiao Guo
Journal:  BMC Cancer       Date:  2014-09-15       Impact factor: 4.430

Review 9.  Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth.

Authors:  Lauren M Kreps; Christina L Addison
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.